U.S. Committee on Oversight and Government Reform

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were trading lower by more than 3 percent early Tuesday afternoon following the release of a memorandum from the U.S. Committee on Oversight and Government Reform. The memorandum, titled "Documents Obtained by Committee from Valeant...